Table V.
Ibandronate pharmacodynamic parameter estimates for urine CTX in postmenopausal women with osteopenia, using integrated bone homeostasis model.
| Parameter (units) | Final Estimate | CV% |
|---|---|---|
| DA (day−1) | 0.842 | 15.2 |
| Imax | 1 a | - |
| h | 2 b | - |
| IC50 (ng/L) | 522 | 8.74 |
| Eb,uCTX (μg/mmolCr) | 31 | 28.7 |
| n (dimensionless) | 5 b | - |
fixed parameter based on indirect response model theory [22].
fixed parameter based on preliminary analysis.